The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preliminary results from CECILIA, an open-label global safety study of bevacizumab (BEV), carboplatin (C) and paclitaxel (P) therapy for metastatic, recurrent or persistent cervical cancer (CC).
 
Andres Redondo
Consulting or Advisory Role - AstraZeneca; PharmaMar; Roche; Tesaro
Research Funding - Roche
Travel, Accommodations, Expenses - PharmaMar; Roche
 
Nicoletta Colombo
Employment - Ignyta (I)
Consulting or Advisory Role - Amgen; AstraZeneca; Clovis Oncology; MSD Oncology; Pfizer; PharmaMar; Roche/Genentech
 
Lydia Mary Dreosti
Honoraria - Merck Sharp & Dohme
Consulting or Advisory Role - Merck Sharp & Dohme
Travel, Accommodations, Expenses - Janssen; Roche
 
Mary McCormack
No Relationships to Disclose
 
Angelica Nogueira Rodrigues
No Relationships to Disclose
 
Margarita Donica
Employment - Roche
 
Leilani Morales
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Antonio González-Martín
Consulting or Advisory Role - AstraZeneca; PharmaMar; Roche; Tesaro
Speakers' Bureau - AstraZeneca; PharmaMar; Roche; Tesaro
Travel, Accommodations, Expenses - AstraZeneca; PharmaMar; Roche; Tesaro